Safety and Efficacy Study of the BioVentrix PliCath HF System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

Also called NCT01568164

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01568164
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Czechia, France, Greece, Italy, Latvia, Lithuania, Poland, Portugal, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01568164. Allocation not applicable; no masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2019-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of the BioVentrix PliCath HF System
Acronym
CONFIGURE-HF
Condition
Heart Failure
Intervention (Device)
PliCath HF System
Lead sponsor
BioVentrix (class: industry)
Collaborator
Ohio State University (class: other)
Collaborator
CDI Centro Diagnostico Italiano S.p.A (class: other)
Collaborator
Advance Research Associates (class: other)

Record details

Record id
cardio:ct-nct01568164
Content hash
4fb53557d856ca6c7b5c1fd62defe9504d937d1c38eef9bbdd63ffdf2ff58ca7